PMC:7205724 / 758-1049
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 56 | 26-34 | Species | denotes | patients | Tax:9606 |
| 57 | 92-101 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 58 | 133-141 | Species | denotes | patients | Tax:9606 |
| 59 | 238-245 | Species | denotes | patient | Tax:9606 |
| 67 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 68 | 50-58 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 69 | 154-162 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 70 | 271-279 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 14-20 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T8 | 4-12 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T9 | 50-58 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T10 | 92-96 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T11 | 154-162 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 271-279 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 14-20 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
| T4 | 102-105 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T6 | 207-222 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5 | 207-222 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T9 | 4-12 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T10 | 50-58 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T11 | 92-101 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
| T12 | 154-162 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T13 | 271-279 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 14-163 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
| T14 | 164-255 | Sentence | denotes | Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 67 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 56 | 26-34 | Species | denotes | patients | Tax:9606 |
| 68 | 50-58 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 57 | 92-101 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 58 | 133-141 | Species | denotes | patients | Tax:9606 |
| 69 | 154-162 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 59 | 238-245 | Species | denotes | patient | Tax:9606 |
| 70 | 271-279 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T119 | 0-3 | IN | denotes | for |
| T120 | 4-12 | NN | denotes | COVID-19 |
| T121 | 14-20 | NN | denotes | Plasma |
| T122 | 21-25 | IN | denotes | from |
| T123 | 26-34 | NNS | denotes | patients |
| T124 | 35-44 | VBN | denotes | recovered |
| T125 | 45-49 | IN | denotes | from |
| T126 | 50-58 | NN | denotes | COVID-19 |
| T127 | 59-63 | WDT | denotes | that |
| T128 | 64-72 | VBZ | denotes | contains |
| T129 | 73-83 | NNS | denotes | antibodies |
| T130 | 84-91 | IN | denotes | against |
| T131 | 92-101 | NN | denotes | SARS-CoV2 |
| T132 | 102-105 | VBZ | denotes | has |
| T133 | 106-111 | VBN | denotes | shown |
| T134 | 112-121 | JJ | denotes | promising |
| T135 | 122-129 | NNS | denotes | results |
| T136 | 130-132 | IN | denotes | in |
| T137 | 133-141 | NNS | denotes | patients |
| T138 | 142-146 | IN | denotes | with |
| T139 | 147-153 | JJ | denotes | severe |
| T140 | 154-162 | NN | denotes | COVID-19 |
| T141 | 164-168 | RB | denotes | Also |
| T142 | 168-169 | -COMMA- | denotes | , |
| T143 | 170-174 | NNP | denotes | IVIG |
| T144 | 174-175 | -COMMA- | denotes | , |
| T145 | 176-184 | VBN | denotes | combined |
| T146 | 185-189 | IN | denotes | with |
| T147 | 190-203 | NN | denotes | moderate-dose |
| T148 | 204-206 | IN | denotes | of |
| T149 | 207-222 | NNS | denotes | corticosteroids |
| T150 | 222-223 | -COMMA- | denotes | , |
| T151 | 224-229 | MD | denotes | might |
| T152 | 230-237 | VB | denotes | improve |
| T153 | 238-245 | NN | denotes | patient |
| T154 | 246-254 | NNS | denotes | outcomes |
| T155 | 256-264 | NN | denotes | Evidence |
| T156 | 265-270 | VBZ | denotes | links |
| T157 | 271-279 | NN | denotes | COVID-19 |
| T158 | 280-282 | TO | denotes | to |
| T159 | 283-291 | JJ | denotes | variable |
| R113 | T120 | T119 | arg2Of | COVID-19,for |
| R114 | T121 | T122 | arg1Of | Plasma,from |
| R115 | T123 | T122 | arg2Of | patients,from |
| R116 | T123 | T124 | arg2Of | patients,recovered |
| R117 | T124 | T125 | arg1Of | recovered,from |
| R118 | T126 | T125 | arg2Of | COVID-19,from |
| R119 | T126 | T127 | arg1Of | COVID-19,that |
| R120 | T126 | T128 | arg1Of | COVID-19,contains |
| R121 | T129 | T128 | arg2Of | antibodies,contains |
| R122 | T129 | T130 | arg1Of | antibodies,against |
| R123 | T131 | T130 | arg2Of | SARS-CoV2,against |
| R124 | T121 | T132 | arg1Of | Plasma,has |
| R125 | T133 | T132 | arg2Of | shown,has |
| R126 | T121 | T133 | arg1Of | Plasma,shown |
| R127 | T135 | T133 | arg2Of | results,shown |
| R128 | T135 | T134 | arg1Of | results,promising |
| R129 | T133 | T136 | arg1Of | shown,in |
| R130 | T137 | T136 | arg2Of | patients,in |
| R131 | T137 | T138 | arg1Of | patients,with |
| R132 | T140 | T138 | arg2Of | COVID-19,with |
| R133 | T140 | T139 | arg1Of | COVID-19,severe |
| R134 | T152 | T141 | arg1Of | improve,Also |
| R135 | T152 | T142 | arg1Of | improve,"," |
| R136 | T143 | T144 | arg1Of | IVIG,"," |
| R137 | T143 | T145 | arg2Of | IVIG,combined |
| R138 | T145 | T146 | arg1Of | combined,with |
| R139 | T147 | T146 | arg2Of | moderate-dose,with |
| R140 | T147 | T148 | arg1Of | moderate-dose,of |
| R141 | T149 | T148 | arg2Of | corticosteroids,of |
| R142 | T152 | T150 | arg1Of | improve,"," |
| R143 | T143 | T151 | arg1Of | IVIG,might |
| R144 | T152 | T151 | arg2Of | improve,might |
| R145 | T143 | T152 | arg1Of | IVIG,improve |
| R146 | T154 | T152 | arg2Of | outcomes,improve |
| R147 | T154 | T153 | arg1Of | outcomes,patient |
| R148 | T155 | T156 | arg1Of | Evidence,links |
| R149 | T157 | T156 | arg2Of | COVID-19,links |
| R150 | T156 | T158 | arg1Of | links,to |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 14-20 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T8 | 4-12 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T9 | 50-58 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T10 | 92-101 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 154-162 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 271-279 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 14-163 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
| T14 | 164-255 | Sentence | denotes | Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |